People with cystic fibrosis who are treated with inhaled dry powder mannitol over a six-month period have improvements in some measures of lung function, a Cochrane review concludes. However there was no evidence to suggest an associated improvement in quality of life, found the review of four studies involving 667 people. Treatment with mannitol ...
Already a member?
Enter your email to keep reading.